Which is cheaper, Shield by Guardant or Oncotype DX?

Shield by Guardant is more affordable at $895 compared to Oncotype DX at $Variable.

What is Shield by Guardant best for?

Shield by Guardant is best for:Adults 45+ wanting non-invasive CRC screening. Key features include:FDA-approved for CRC|Medicare coverage|Blood-based alternative to colonoscopy|Primary screening option

What is Oncotype DX best for?

Oncotype DX is best for:Breast cancer patients deciding on chemotherapy. Key features include:Predicts chemotherapy benefit|Recurrence risk score|Tumor tissue analysis|Guides treatment decisions

What's the difference between Shield by Guardant and Oncotype DX?

Shield by Guardant and Oncotype DX are both cancer screening services. Compare their pricing, features, and methodology to find the best fit for your needs.

Shield by Guardant vs Oncotype DX

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Shield by Guardant

FDA approved

$895

Colorectal only

Oncotype DX

Guideline recommended

Variable

Breast recurrence risk

Test Performance

Feature	Shield by Guardant	Oncotype DX
Price	$895	Variable
Cancers Detected	Colorectal only	Breast recurrence risk
Sensitivity	84% for CRC	N/A
Specificity	90%	N/A
Sample Type	Blood draw	Tumor tissue
FDA Status	FDA approved	Guideline recommended

Visit Shield by Guardant Visit Oncotype DX Compare All